One Drop announced today that it added former Sanofi executive Rachel Yap Martens and former ResMed executive Gina Merchant to its executive team.
Yap Martens is set to become One Drop’s senior VP of consumer solutions and commercial strategy, having previously served as Sanofi’s head of U.S. diabetes integrated care. Martens’ new role includes attempting to grow One Drop’s consumer user base to bring improved outcomes to individuals with diabetes and other chronic conditions.
New York-based One Drop brought Merchant on to be its new VP of behavioral design & science. The former senior behavioral scientist at ResMed has responsibilities that include incorporating behavioral science into the company’s core user experience and bringing data-driven behavioral interventions to One Drop’s offering.
“Martens’ and Merchant’s respective expertise and perspectives will be critical as we continue to provide individuals with the tools and support they need to enable effective self-care outside the doctor’s office,” One Drop founder & CEO Jeff Dachis said in a news release. “These additions to our team will enable One Drop to capitalize on what we predict to be a huge shift towards consumer-led healthcare in 2020.”
One Drop develops a compact blood glucose monitor compatible with the iOS Health app and the Apple Watch. The device is connected through Bluetooth and draws a small amount of blood to measure a user’s blood glucose level that can be tracked through the Health app.
In June 2019, the company expanded its AI-powered predictive insights to include eight-hour blood glucose forecasts for its mobile app users with Type 2 diabetes. The app also offers a personal health assistant for monitoring medication, food and physical activity, along with other health markers. The product is available for sale through common marketplaces like Walmart, Amazon and Best Buy.